Cargando…

Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer

BACKGROUND: Ferroptosis is a newly discovered mode of cell death distinct from apoptosis and necrosis, and its activation contributes to anticancer therapy in a variety of cancers. However, the prognostic value of ferroptosis-related genes in non-small cell lung cancer (NSCLC) remains to be further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Fangfang, Zheng, Yushi, Li, Xiaoling, Luo, Hui, Luo, Lianxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549233/ https://www.ncbi.nlm.nih.gov/pubmed/34702254 http://dx.doi.org/10.1186/s12935-021-02267-2

Ejemplares similares

Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
por: Li, Xiaoling, et al.
Publicado: (2020)

Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma
por: Luo, Lianxiang, et al.
Publicado: (2022)

Fascaplysin Induces Apoptosis and Ferroptosis, and Enhances Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) by Promoting PD-L1 Expression
por: Luo, Lianxiang, et al.
Publicado: (2022)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Long non-coding RNA LSAMP-1 is down-regulated in non-small cell lung cancer and predicts a poor prognosis
por: Gong, Wei, et al.
Publicado: (2022)

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
por: Meng, Yu, et al.
Publicado: (2023)

Exploration in the mechanism of fucosterol for the treatment of non-small cell lung cancer based on network pharmacology and molecular docking
por: Li, Xiaoling, et al.
Publicado: (2021)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer
por: Zhang, Zeyu, et al.
Publicado: (2021)

Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy
por: Zheng, Yushi, et al.
Publicado: (2023)

Pyroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Non-Small-Cell Lung Cancer
por: Luo, Lianxiang, et al.
Publicado: (2022)

SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications
por: Luo, Lianxiang, et al.
Publicado: (2021)

AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
por: ZHU, Hong, et al.
Publicado: (2018)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis
por: Li, Huiping, et al.
Publicado: (2020)

AKR1C1 Protects Corneal Epithelial Cells Against Oxidative Stress-Mediated Ferroptosis in Dry Eye
por: Zuo, Xin, et al.
Publicado: (2022)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation
por: Deng, Huan, et al.
Publicado: (2021)

Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma
por: Deng, Biao, et al.
Publicado: (2022)

High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells
por: Tian, He, et al.
Publicado: (2016)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
por: Ju, Lixia, et al.
Publicado: (2013)

BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer
por: Hu, Tao, et al.
Publicado: (2015)

AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming
por: Chang, Lin-Lin, et al.
Publicado: (2022)

Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma
por: Jin, Yi-Xiang, et al.
Publicado: (2019)

Roles of AKR1C3 in malignancy
por: Xiao, Xin-Zhu, et al.
Publicado: (2021)

Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
por: Zeng, Chen-Ming, et al.
Publicado: (2017)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
por: Fu, Zhiwen, et al.
Publicado: (2022)

Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
por: Yao, Jie, et al.
Publicado: (2021)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues
por: Ren, Fanghui, et al.
Publicado: (2015)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses
por: Arthur, Jonathan W., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_29qnr82mcfjn3hlg4fujgtve40